Insider Purchases: Inside the Buy
Tag: Funanc1al Investing
Freshworks Insider Buys: Are FRSH Shares Finally Getting… Fresh?
Freshworks insiders just went shopping — and not for office snacks. The CEO/President and CFO/COO bought shares, hinting that FRSH may finally be ready to rise. Here’s the fun, funny breakdown of why insiders love it… and whether you should too.
New CEO Buys TMUS: Insider Confidence or Lost Contacts?
New T-Mobile CEO Srini Gopalan wasted no time showing confidence — buying nearly $2 million of TMUS stock right after taking charge. With record customer growth, a raised outlook, and juicy cash flow, the question is: smart signal or misdialed enthusiasm? 📱💰
Dexcom’s COO Just Bought ~$1M of Stock — Sweet Signal or Just a Sugar Rush?
Dexcom’s insider buy just spiked the glucose of Wall Street chat rooms. The COO is buying big, AI features are rolling, and institutions own almost everything. Is DXCM a sweet buy or a sugar rush in disguise? 🍬📈
Insiders Just Boarded: Will NCLH’s Next Port Be Higher Prices?
Three top insiders at Norwegian Cruise Line (NCLH) bought shares on the same day—while bookings hit records and revenue sails higher. Debt is still the big wave to watch, but valuation looks reasonable for a cyclical. Here’s what cluster buys, guidance, and leverage really mean for the stock.
President & CEO Bought Shares of Enphase Energy: Time To Buy ENPH?
Enphase’s stock has been sunburned — but its CEO is buying, institutions are still in, and the long-term clean-energy runway remains bright. We dig into the numbers, the market mood, and whether ENPH could be an early-cycle solar rebound opportunity or a falling panel. ☀️📉➡️⚡️📈
CEO/COB at Cigna Is Buying CI. Is He Signaling: Time To Buy?
Cigna’s CEO is buying big — and Wall Street is paying attention. With earnings up, a pharmacy-benefit shake-up underway, and valuations looking healthy, CI might just be the quiet value stock investors have been waiting for. Let’s break it down — and have fun doing it. 😎💊📈
Two Directors Bought Shares of Everest Group (EG) Cheaper Than the CEO Did 6 Months Ago: Will Buying Now Culminate in Profits?
Two Everest Group directors just bought stock around $306–$307—below the CEO’s June buy—while the company cleans house with a $1.2B adverse development cover and a renewal-rights sale to AIG. Institutions own essentially all the float, short interest is low, and forward P/E looks cheap. Here’s the risk/reward.
Investor & Insider James Breyer Just Bought Blackstone (BX). Should You Sip the Alt-Assets Kool-Aid—or Sit It Out?
Blackstone remains the alt-assets apex predator: $1.24T AUM, rising perpetual capital, and a fresh insider buy from director James Breyer. We unpack fundraising momentum, distributable earnings, variable dividends, key risks (rates, exits), and why dips may be gifts for long-term investors.
CEO Bought Shares of Booz Allen Hamilton: Time to Indulge
Booz Allen just flashed insider conviction: CEO Horacio Rozanski purchased ~$2M of BAH stock. Despite near-term revenue pressure from funding delays, the firm sports a record backlog, mission-critical AI/cyber programs, and steady capital returns. We unpack the bull/bear, valuation, and what could flip the narrative from pause to play.
CEO, COB, President All Bought Shares of FTI Consulting (FCN). It’s the Same Person—Still… Should You Buy Too?
FTI Consulting just posted record EPS while its tri-titled chief bought $1.13M of stock and the board added $500M to buybacks. A cycle-balanced franchise that compounds through booms, busts, and boardroom “oh-no’s.”